Don’t miss a beat as our guest Dr. Noble Maleque guides us through dominating narrow complex tachyarrhythmias (while keeping our own heart rates under control too). @Nobility75 (Emory University)
Claim CME for this episode at curbsiders.vcuhealth.org!
Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME

When responding to a page or rapid response for a tachyarrhythmia, ask a few key questions to set you up for success when you arrive in the room. The first box of AHA tachycardia algorithm outlines these questions and suggests initial actions:
Determining whether the patient is stable or unstable is the first decision to make to identify the appropriate algorithm to use.
Unstable patients have hypotension or end-organ dysfunction from their tachyarrhythmia. Examples of end-organ dysfunction include altered mental status, chest pain, or acute heart failure. Per the AHA tachycardia algorithm, these patients need urgent synchronized cardioversion, and may require ICU or step-down care, so call cardiology.
Stable patients may have symptoms (e.g. palpitations) but do not have evidence of end-organ dysfunction. These patients afford you more time to determine the type of tachyarrhythmia, identify and manage any underlying causes, and administer appropriate antiarrhythmics if necessary.
Dr. Maleque also acknowledges that it’s normal to feel nervous in high-acuity situations like this. He encourages thinking out loud and getting input from nursing staff on a patient’s baseline and recent symptoms. He also reiterates that everyone in the room must feel comfortable with the patient’s level of care and to consider escalation of care if indicated.
Once you have determined whether the patient is stable or unstable, the next branch point in the AHA tachycardia algorithm is determining whether the tachyarrhythmia is narrow or wide complex. Rhythms are wide complex if they are equal to or longer than 0.12 seconds, or 120 milliseconds. This equates to three small boxes on a printed EKG.
Wide complex tachyarrhythmias should be considered ventricular tachycardia until proven otherwise. These should prompt cardiology consultation and are outside of the scope of today’s episode.
Once you’ve determined that your patient has a narrow complex tachyarrhythmia, the next step is to identify the general type of arrhythmia. Dr. Maleque suggests placing the arrhythmia into one of a few buckets instead of spending valuable time identifying the exact subtype. His expert opinion is that precise identification isn’t essential for bedside management with some rare exceptions (e.g. identifying pre-excitation conditions like Wolff-Parkinson-White, in which case nodal blockers may worsen tachycardia). Plus, even experts have a difficult time determining the rhythm when it is very fast.
The major buckets that Dr. Maleque identifies are:
Determining whether the rhythm is regular or irregular can be challenging when the rate is fast, as the p waves and t waves can overlap. Several clues can help you make this determination:
First and foremost, identify and treat any potential arrhythmia trigger(s) like infection and hypo- or hypervolemia. For sinus tachycardia, this is your only management option. For other narrow complex tachyarrhythmias such as SVT or Afib with RVR, physical exam maneuvers and/or antiarrhythmic drugs are needed.
There are many vagal maneuvers at your disposal, including the Valsalva maneuver, the modified Valsalva, carotid sinus massage, and water immersion, especially cold water immersion of the face (to elicit the “diving reflex”).
In a randomized control trial of patients presenting to the emergency department with SVT, the modified Valsalva maneuver was more efficacious for restoring sinus rhythm compared to a standard valsalva (43% vs 17% success rate) (Appelboam, 2015). An older, smaller study also compared the efficacy of the Vаlsalva maneuver, right carotid sinus massage, left carotid massage, and eliciting the diving reflex. That study found that the supine Valsаlvа maneuver was the most successful for terminating SVT (54%), followed by the diving reflex (17%), and performing carotid sinus massage on the right (17%) and left (5%) sides (Mehta, 1988).
The first-line pharmacologic option is adenosine as it can be both diagnostic and therapeutic. Adenosine effectively terminates >80% of cases of SVT, but there are important contraindications to use and adverse effects. Contraindications include reactive airway disease (e.g. COPD) or severe coronary artery disease. Side effects are often uncomfortable for patients and include flushing, palpitations, and the feeling of impending doom. Adenosine can also cause clinician discomfort, as it causes transient asystole, requiring continuous EKG monitoring during administration. Adenosine has a very short half-life (<5 seconds) and thus must be administered at or above the antecubital fossa, via a 3-way stopcock with saline immediately flushing it. Doses escalate from 6mg → 12mg → 12mg if the desired effect is not achieved.
Second-line AV nodal blocking agents for SVT and first-line rate control agents for Afib with RVR include metoprolol and diltiazem. Diltiazem is dosed 0.25 mg/kg IV for the first dose, and 0.35 mg/kg after 15 minutes for the second dose, if necessary. Dr. Maleque observes that lower doses of diltiazem are often used (e.g. 10 mg) due to fear of hypotension. Metoprolol is dosed 5 mg IV every 5-10 minutes as needed for up to 3 doses. Both of these drugs are negative inotropes, so caution is warranted in patients with acute decompensated heart failure and an unknown ejection fraction. Amiodarone is often a safer choice for such patients. Amiodarone is dosed 150 mg IV over 10 minutes to lower the risk of hypotension, followed by a 1 mg/min infusion. Digoxin is also an option, but this is rarely used in a rapid response situation unless there is a contraindication to amiodarone due to its slower onset of action.
Anticoagulation decisions should be made based on the patient’s CHA₂DS₂-VASc score.
Listeners will develop a framework to approach the triage, evaluation, and management of narrow complex tachyarrhythmias.
After listening to this episode listeners will…
Dr. Maleque reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.
Maleque N, Coleman CG, Trubitt ME, Amin M, Williams PN, Watto MF. “#473 Rapid Response Series: Narrow Complex Tachyarrhythmias with Dr. Noble Maleque”. The Curbsiders Internal Medicine Podcast. thecurbsiders.com/category/curbsiders-podcast March 3rd 2025.
Start your free trial today, no credit card needed. Usecode: CURB50 to get $50 off your first month when you subscribe at Freed.ai
Download Grammarly for FREE at grammarly.com/PODCAST
Visit free-to-use sponsor at Locumstory.com
Producer, writer, Infographic, cover art, and show notes by: Caroline Coleman, MD
Hosts: Meredith Trubitt, MD and Monee Amin, MD
Reviewer: Rahul Ganatra, MD MPH
Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
Technical Production: PodPaste
Guest: Noble Maleque, MD
The Curbsiders are partnering with VCU Health Continuing Education to offer continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org and search for this episode to claim credit.
Got feedback? Suggest a Curbsiders topic. Recommend a guest. Tell us what you think.
We love hearing from you.

Yes, you can now join our exclusive community of core faculty at Kashlak Memorial Hospital along with all the perks:
Notice
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the cookie policy. Denying consent may make related features unavailable.
Close this notice to consent.